U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients

по Ho, Samuel B., Aqel, Bashar, Dieperink, Eric, Liu, Shanglei, Tetrick, Lori, Falck-Ytter, Yngve, DeComarmond, Charles, Smith, Coleman I., McKee, Daniel P., Boyd, William, Kulig, Clark C., Bini, Edmund J., Pedrosa, Marcos C.
Опубликовано 2011